Listing 1 - 2 of 2 |
Sort by
|
Choose an application
This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.
apolipoprotein --- lipids --- risk stratification --- proprotein convertase subtilisin-kexin type 9 (PCSK9) --- vaspin --- sphingolipids --- PCSK9 --- ceramides --- atrial fibrillation --- circular RNA --- STEMI --- cholesterol --- lipoproteins --- cardiovascular disease (CVD) --- coronary artery bypass grafting --- atherosclerosis --- statin --- LDL subfractions --- acute kidney injury --- dyslipidemia --- gene expression --- NSTEMI --- NAFLD --- hyperlipidemia --- nonstatin --- cholesteryl ester transfer protein --- low-density lipoprotein cholesterol --- anacetrapib --- HDL --- acute coronary syndrome --- miRNA --- cardiovascular risk --- pleiotropic actions --- genetic --- ABCA1 --- sdLDL --- cardiovascular disease --- proprotein convertase subtilisin/kexin type 9 --- inclisiran --- reverse cholesterol transport --- sterol --- small interfering RNA (siRNA) --- RNA-binding proteins --- cardiovascular diseases --- NASH --- low-density lipoprotein-cholesterol (LDL-C) --- stroke --- nutrigenetics --- type 2 diabetes --- statins --- sphingomyelin --- hepatic fibrosis --- diabetes
Choose an application
The natriuretic peptides (NPs) family includes a class of hormones and their receptors needed for the physiological control of cardiovascular functions. The discovery of NPs provided a fundamental contribution into our understanding of the physiological regulation of blood pressure, and of heart and kidney functions. NPs have also been implicated in the pathogenesis of several cardiovascular diseases (CVDs), including hypertension, atherosclerosis, heart failure, and stroke. A fine comprehension of the molecular mechanisms dependent from NPs and underlying the promotion of cardiovascular damage has contributed to improve our understanding of the molecular basis of all major CVDs. Finally, the opportunity to target NPs in order to develop new therapeutic tools for a better treatment of CVDs has been developed over the years. The current Special Issue of the Journal covers all major aspects of the molecular implications of NPs in physiology and pathology of the cardiovascular system, including NP-based therapeutic approaches.
postmortem biochemistry --- medulla --- animal models --- remodeling --- BNP --- PCSK9 --- guanylyl cyclase/natriuretic peptide receptor-A --- cardiorenal syndrome --- forensic medicine --- preserved ejection fraction --- kidney --- renin-angiotensin-aldosterone system --- atrial fibrillation --- vasopressor --- congestive heart failure --- atrial natriuretic peptide --- gene-knockout --- obesity --- heart failure --- angiogenesis --- adipose tissue --- vascular --- LDL receptor --- metabolic syndrome --- linkage analysis --- cardiometabolic disease --- cardiomyocyte --- cardiac dysfunction --- cardiac hypertrophy --- insulin --- lipid metabolism --- cGMP --- Idiopathic Pulmonary Arterial Hypertension (IPAH) --- Natriuretic Peptide Clearance Receptor (NPR-C) signaling --- gene-duplication --- renin–angiotensin system --- natriuretic peptides --- angiotensin receptor–neprilysin inhibitor --- cardiac remodelling --- ARNi --- NT-proBNP --- inflammation --- pulmonary arterial hypertension --- vascular homeostasis --- endothelial cell --- Atrial Natriuretic peptide --- natriuretic peptide --- vasodilator --- stroke --- genetic variants --- arterial hypertension --- fibroblast --- MANP --- hypertension --- guanylyl cyclase receptor A
Listing 1 - 2 of 2 |
Sort by
|